🔎 Trials Near Me

Beranda › Gagal Ginjal › Missouri

Uji klinis Gagal Ginjal di Missouri

6 studi untuk Gagal Ginjal mencari peserta di lokasi di Missouri.

Kota di Missouri

Teks studi resmi (Bahasa Inggris)

Study of Orellanine in Metastatic Clear-Cell or Papillary Renal Cell Carcinoma

  • Washington University in St. Louis, St Louis
Menerima pesertaFase 1/2
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 1 Okt 2026 · NCT05287945

Combined Dose-Finding and CV Outcomes Study With CSL300 (Clazakizumab) in Adult Subjects With ESKD Undergoing Dialysis (POSIBIL6ESKD)

  • Clinical Research Consultants, Kansas City
  • Kansas City VA Medical Center, Kansas City
  • DCI-Rockhill, Kansas City
Menerima pesertaFase 2/3
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 21 Sep 2026 · NCT05485961

A Study to Evaluate AZD7760 Safety and Pharmacokinetics in Healthy Adults (Phase I) and Adults With End-stage Kidney Disease on Hemodialysis With a Central Venous Catheter (Phase IIa)

  • Research Site, Kansas City
Menerima pesertaFase 1/2Sukarelawan sehat diterima
Usia 18 hingga 55 · Semua jenis kelamin · Diperbarui 14 Agu 2026 · NCT06749457

International (Pediatric) Peritoneal Biobank

  • Children's Mercy Hospital, Kansas City
Menerima pesertaStudi observasionalSukarelawan sehat diterima
1 Day – 90 Years · Semua jenis kelamin · Diperbarui 30 Apr 2026 · NCT01893710

Sotagliflozin to Slow Kidney Function Decline in Persons With Type 1 Diabetes and Diabetic Kidney Disease

  • Washington University, St Louis
Menerima pesertaFase 3
Usia 18 hingga 75 · Semua jenis kelamin · Diperbarui 24 Mar 2026 · NCT06217302

SAVE-FistulaS: the SelfWrap-Assisted ArterioVEnous Fistulas Study

  • University of Missouri, Columbia
  • Saint Louis University, St Louis
  • Washington University School of Medicine, St Louis
Menerima peserta
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 17 Feb 2026 · NCT06001827

Dari ClinicalTrials.gov, data diambil 2 Okt 2026. Setiap studi menetapkan kriteria kelayakannya sendiri; tim studi yang menentukan siapa yang bisa bergabung.